Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc., 82403 [2023-25992]
Download as PDF
<![CDATA[
82403
Federal Register / Vol. 88, No. 225 / Friday, November 24, 2023 / Notices
Controlled substance
Drug code
Beta-hydroxyfentanyl ..............................................................................................................................................................
Beta-hydroxy-3-methylfentanyl ...............................................................................................................................................
3-Methylthiofentanyl ...............................................................................................................................................................
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) ....................................................................
Thiofentanyl ............................................................................................................................................................................
Beta-hydroxythiofentanyl ........................................................................................................................................................
Ocfentanil ...............................................................................................................................................................................
beta′-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide; also known as b′-phenyl fentanyl; 3phenylpropanoyl fentanyl).
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide .................................................................................
Crotonyl fentanyl ((E-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide) ........................................................................
Cyclopropyl Fentanyl ..............................................................................................................................................................
ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide; also known as 2-fluorobutyryl
fentanyl).
Nabilone .................................................................................................................................................................................
Alphaprodine ..........................................................................................................................................................................
Levomethorphan .....................................................................................................................................................................
Racemethorphan ....................................................................................................................................................................
Alfentanil .................................................................................................................................................................................
The company plans to import the
listed controlled substances for
distribution for analytical testing
purposes. No other activities for these
drug codes are authorized for this
registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Drug Enforcement Administration
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
[Docket No. DEA–1297]
SUPPLEMENTARY INFORMATION:
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023-25989 Filed 11-22-23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Bulk Manufacturer of Controlled
Substances Application: Sigma Aldrich
Research Biochemicals, Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Sigma Aldrich Research
Biochemicals, Inc. has applied to be
registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before January 23, 2024. Such
SUMMARY:
ddrumheller on DSK120RN23PROD with NOTICES1
persons may also file a written request
for a hearing on the application on or
before January 23, 2024.
VerDate Sep<11>2014
21:46 Nov 22, 2023
Jkt 262001
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on October 27, 2023,
Sigma Aldrich Research Biochemicals,
Inc., 400–600 Summit Drive, Burlington,
Massachusetts 01803, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substance(s):
Controlled substance
Lisdexamfetamine .........
Drug
code
1205
Schedule
I
The company plans to manufacture
the listed controlled substances as
reference standards. No other activities
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
Schedule
9830
9831
9833
9834
9835
9836
9838
9842
I
I
I
I
I
I
I
I
9843
9844
9845
9846
I
I
I
I
7379
9010
9210
9732
9737
II
II
II
II
II
for these drug codes are authorized for
this registration.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023–25992 Filed 11–22–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
[OMB Number 1121–0330]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Law
Enforcement Congressional Badge of
Bravery
Office of Justice Programs,
Department of Justice.
ACTION: 30-Day notice.
AGENCY:
The Office of Justice
Programs, Bureau of Justice Assistance
(BJA), Department of Justice (DOJ), will
be submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection
was previously published in the Federal
Register on September 15, allowing a
60-day comment period.
DATES: Comments are encouraged and
will be accepted for 30 days until
December 26, 2023.
FOR FURTHER INFORMATION CONTACT: If
you have comments especially on the
estimated public burden or associated
response time, suggestions, or need a
copy of the proposed information
collection instrument with instructions
or additional information, please
contact: Gregory Joy at 202–514–1369,
Policy Advisor, Bureau of Justice
Assistance, 810 7th Street NW,
SUMMARY:
E:\FR\FM\24NON1.SGM
24NON1
]]>Agencies
[Federal Register Volume 88, Number 225 (Friday, November 24, 2023)]
[Notices]
[Page 82403]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-25992]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1297]
Bulk Manufacturer of Controlled Substances Application: Sigma
Aldrich Research Biochemicals, Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Sigma Aldrich Research Biochemicals, Inc. has applied to be
registered as a bulk manufacturer of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for
further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
January 23, 2024. Such persons may also file a written request for a
hearing on the application on or before January 23, 2024.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on October 27, 2023, Sigma Aldrich Research
Biochemicals, Inc., 400-600 Summit Drive, Burlington, Massachusetts
01803, applied to be registered as a bulk manufacturer of the following
basic class(es) of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Lisdexamfetamine....................... 1205 I
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
as reference standards. No other activities for these drug codes are
authorized for this registration.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023-25992 Filed 11-22-23; 8:45 am]
BILLING CODE P
